Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 2000 May 30;162(11):1571–1572.

Folic acid: the opportunity that still exists

J G Hall 1
PMCID: PMC1231337  PMID: 10862231

Full Text

The Full Text of this article is available as a PDF (192.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry R. J., Li Z., Erickson J. D., Li S., Moore C. A., Wang H., Mulinare J., Zhao P., Wong L. Y., Gindler J. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999 Nov 11;341(20):1485–1490. doi: 10.1056/NEJM199911113412001. [DOI] [PubMed] [Google Scholar]
  2. Bonin M. M., Bretzlaff J. A., Therrien S. A., Rowe B. H. Knowledge of periconceptional folic acid for the prevention of neural tube defects. The missing links. Northeastern Ontario Primary Care Research Group. Arch Fam Med. 1998 Sep-Oct;7(5):438–442. doi: 10.1001/archfami.7.5.438. [DOI] [PubMed] [Google Scholar]
  3. Botto L. D., Khoury M. J., Mulinare J., Erickson J. D. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics. 1996 Nov;98(5):911–917. [PubMed] [Google Scholar]
  4. Chung C. S., Myrianthopoulos N. C. Congenital anomalies: mortality and morbidity, burden and classification. Am J Med Genet. 1987 Jul;27(3):505–523. doi: 10.1002/ajmg.1320270304. [DOI] [PubMed] [Google Scholar]
  5. Czeizel A. E., Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 Dec 24;327(26):1832–1835. doi: 10.1056/NEJM199212243272602. [DOI] [PubMed] [Google Scholar]
  6. Czeizel A. E. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ. 1993 Jun 19;306(6893):1645–1648. doi: 10.1136/bmj.306.6893.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Czeizel A. E. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet. 1996 Mar 15;62(2):179–183. doi: 10.1002/(SICI)1096-8628(19960315)62:2<179::AID-AJMG12>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  8. Hall J. G., Solehdin F. Folate and its various ramifications. Adv Pediatr. 1998;45:1–35. [PubMed] [Google Scholar]
  9. Hayes C., Werler M. M., Willett W. C., Mitchell A. A. Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol. 1996 Jun 15;143(12):1229–1234. doi: 10.1093/oxfordjournals.aje.a008710. [DOI] [PubMed] [Google Scholar]
  10. House J. D., March S. B., Ratnam S., Ives E., Brosnan J. T., Friel J. K. Folate and vitamin B12 status of women in Newfoundland at their first prenatal visit. CMAJ. 2000 May 30;162(11):1557–1559. [PMC free article] [PubMed] [Google Scholar]
  11. Li D. K., Daling J. R., Mueller B. A., Hickok D. E., Fantel A. G., Weiss N. S. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology. 1995 May;6(3):212–218. doi: 10.1097/00001648-199505000-00004. [DOI] [PubMed] [Google Scholar]
  12. Ma J., Stampfer M. J., Giovannucci E., Artigas C., Hunter D. J., Fuchs C., Willett W. C., Selhub J., Hennekens C. H., Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997 Mar 15;57(6):1098–1102. [PubMed] [Google Scholar]
  13. McCully K. S. Homocysteine and vascular disease. Nat Med. 1996 Apr;2(4):386–389. doi: 10.1038/nm0496-386. [DOI] [PubMed] [Google Scholar]
  14. Meyer R. E., Oakley G. P., Jr Folic acid fortification. Lancet. 1999 Dec 18;354(9196):2168–2168. doi: 10.1016/s0140-6736(05)77074-4. [DOI] [PubMed] [Google Scholar]
  15. Oakley G. P., Jr Eat right and take a multivitamin. N Engl J Med. 1998 Apr 9;338(15):1060–1061. doi: 10.1056/NEJM199804093381509. [DOI] [PubMed] [Google Scholar]
  16. Omenn G. S., Beresford S. A., Motulsky A. G. Preventing coronary heart disease: B vitamins and homocysteine. Circulation. 1998 Feb 10;97(5):421–424. doi: 10.1161/01.cir.97.5.421. [DOI] [PubMed] [Google Scholar]
  17. Peterson D. E., Sahm D. F. Fluoroquinolone resistance in Streptococcus pneumoniae. N Engl J Med. 1999 Nov 11;341(20):1547–1548. [PubMed] [Google Scholar]
  18. Shaw G. M., Lammer E. J., Wasserman C. R., O'Malley C. D., Tolarova M. M. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet. 1995 Aug 12;346(8972):393–396. doi: 10.1016/s0140-6736(95)92778-6. [DOI] [PubMed] [Google Scholar]
  19. Shaw G. M., O'Malley C. D., Wasserman C. R., Tolarova M. M., Lammer E. J. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 1995 Dec 4;59(4):536–545. doi: 10.1002/ajmg.1320590428. [DOI] [PubMed] [Google Scholar]
  20. Tolarova M., Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology. 1995 Feb;51(2):71–78. doi: 10.1002/tera.1420510205. [DOI] [PubMed] [Google Scholar]
  21. Tucker K. L., Mahnken B., Wilson P. W., Jacques P., Selhub J. Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. JAMA. 1996 Dec 18;276(23):1879–1885. doi: 10.1001/jama.1996.03540230029031. [DOI] [PubMed] [Google Scholar]
  22. Turner L. A., McCourt C. Folic acid fortification: what does it mean for patients and physicians? CMAJ. 1998 Mar 24;158(6):773–776. [PMC free article] [PubMed] [Google Scholar]
  23. Welch G. N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998 Apr 9;338(15):1042–1050. doi: 10.1056/NEJM199804093381507. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES